Skip to main content
Swing Capital

Nureca Ltd

NSE: NURECA BSE: 543264Healthcare

Nureca Ltd (NURECA) is a Healthcare company listed on NSE: NURECA | BSE: 543264. With a market cap of ₹256 Cr and ROCE of 0.33%, ROE of 0.36%, it operates in the Indian Healthcare sector.

₹268
52W: ₹200 — ₹344
PE 28.4 · Book ₹206 · +30% vs book
Market Cap₹256 Cr
Stock P/E28.4Price to Earnings
ROCE0.33%Return on Capital
ROE0.36%Return on Equity
Div. Yield0%Face Value ₹10

Strengths

  • +Company is almost debt free.
  • +Company is expected to give good quarter
  • +Promoter holding has increased by 3.12% over last quarter.

Weaknesses

  • −The company has delivered a poor sales growth of 2.89% over past five years.
  • −Company has a low return on equity of -1.93% over last 3 years.
  • −Earnings include an other income of Rs.9.26 Cr.
  • −Working capital days have increased from 237 days to 403 days

Shareholding Pattern

Promoters68.09%
FIIs0.28%
DIIs0.24%
Public31.39%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters63.24%63.78%▲0.564.06%▲0.364.3%▲0.264.33%▲0.064.97%▲0.664.97%68.09%▲3.1
FIIs0.07%0.69%▲0.60.36%▼0.31.07%▲0.70.07%▼1.00.07%0.08%▲0.00.28%▲0.2
DIIs0%0%0.04%▲0.00.04%0.04%0.04%0.04%0.24%▲0.2
Public36.69%35.53%▼1.235.54%▲0.034.59%▼0.935.56%▲1.034.92%▼0.634.91%▼0.031.39%▼3.5

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales31.3522.3719.5623.3132.3727.2131.7534.3237.8439.64
Expenses30.3126.824.3226.2335.0331.9531.1935.435.2237.25
Operating Profit1.04-4.43-4.76-2.92-2.66-4.740.56-1.082.622.39
OPM %3.32%-19.8%-24.34%-12.53%-8.22%-17.42%1.76%-3.15%6.92%6.03%
Net Profit2.640.08-4.411.2-0.65-3.292.070.553.143.23
EPS ₹2.640.08-4.411.2-0.65-3.292.070.553.143.39

AI Insights

Revenue Trend

TTM revenue at ₹144Cr, up 25.2% YoY. OPM at 3%.

Debt Position

Borrowings at ₹3Cr. Debt-to-equity ratio: 0.02x. Healthy balance sheet.

Institutional Flow

DIIs: 0.24% (+0.24pp change). FIIs: 0.28% (+0.18pp change). Promoters hold 68.09%.

Margin & Efficiency

ROCE improving from 0% (Mar 2017) to 0% (Mar 2025). Working capital days: 403.

Valuation

PE 28.4x with 0.33% ROCE. Price is 30% above book value of ₹206. Dividend yield: 0%.

Recent Announcements